Staphylococcus IVDs

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

buyitnow

PAR PAR (PAR)
09-11-2017

MAH:

Cepheid Holdings Pty Ltd

class:

Class 3

manufactured_by:

Cepheid 904 Caribbean Drive, Sunnyvale, California, 94089 United States Of America

therapeutic_area:

CT797 - Staphylococcus IVDs

therapeutic_indication:

The Xpert MRSA and MRSA NxG, is a qualitative IVD for the detection of methicillin-resistant S. aureus DNA from nasal swabs. The test utilizes automated real-time PCR for the amplification of MRSA specific DNA targets. The Xpert MRSA and MRSA NxG is intended to aid in the prevention and control of MRSA infections in healthcare settings. The Xpert MRSA and MRSA NxG are not intended to diagnose, guide, or monitor treatment for MRSA infections, or provide results of susceptibility to methicillin

authorization_status:

A

authorization_date:

2014-03-31